Worldwide Osteoporosis Market Analysed and Forecast by Renub Research in New Report Now Available at MarketPublishers.com
02 Oct 2015 • by Natalie Aster
LONDON – The global osteoporosis market is expected to be valued at over USD 40 billion by 2019. India and China together have nearly 80% of all patients with osteoporosis. Whilst this in case of hip fractures both India and China account for over 60% the world’s osteoporosis patients. However, in market terms, the USA captures the largest share of the worldwide osteoporosis market, with China and Japan following after. Eli Lilly and Amgen are leading players in the osteoporosis drugs market.
The major drivers of the market growth include, among others, widespread vitamin D deficiency and low intake of calcium, constantly increasing ageing population and life expectancy globally. Dearth of reimbursement and/or other restrictions for reimbursement, limited access of diagnostic tools and low health professional and public awareness, and lack of government osteoporosis policies, guidelines and national health priority in the countries of the APAC region present some of the key challenges facing the market today.
New research report “Global Osteoporosis Market, Patients, Companies & Forecast” drawn up by Renub Research provides an all-encompassing analysis of the present-day condition of the osteoporosis market and the possible future development over the next five years.
It presents an in-depth analysis and forecast of the world’s osteoporosis and hip fracture patients population; offers an all-round analysis and forecast of the worldwide osteoporosis marketplace; gives data on the market shares of global osteoporosis patients population and hip fracture patients population, of the global osteoporosis market, and also companies producing osteoporosis drugs. The study contains detailed analyses of the market across the major countries, such as India, China, Japan, Korea, Brazil, Russia, the UK, France, Germany and the USA; covers the level of awareness, guidelines and government policies in the nations reviewed; gives insights into reimbursement of medication country-wise. The report presents an insightful analysis of the leading players, including Merck, Sanofi, Novartis, Eli Lilly and Amgen, along with coverage of osteoporosis drugs sales and forecasts. An all-round assessment of key drivers and challenges of the market is available as well.
Global Osteoporosis Market, Patients, Companies & Forecast
Published: September, 2015
Price: US$ 1,100.00
More reports by the publisher are available at Renub Research page.